BrainsWay Ltd. ( BRSYF) - Key Metrics
BRSYF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.42 | $0.07 | $0.16 | $0.14 |
| 2026Q1 | $0.41 | $0.06 | $0.03 | $0.01 |
| 2025Q4 | $0.40 | $0.08 | -$0.02 | -$0.02 |
| 2025Q3 | $0.36 | $0.04 | $0.04 | $0.02 |
| 2025Q2 | $0.31 | $0.05 | $0.31 | $0.28 |
BRSYF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 62.65 |
| 2026Q1 | 0% | 49.46 |
| 2025Q4 | 0% | 27.28 |
| 2025Q3 | 0% | 34.31 |
| 2025Q2 | 0% | 17 |
BRSYF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.82% | 0% |
| 2026Q1 | 0.09% | 0% |
| 2025Q4 | -0.24% | 0% |
| 2025Q3 | 0.28% | 0% |
| 2025Q2 | 8.14% | 0% |
BRSYF
Price: $12.60
52 week price:
Earnings Per Share: 0.23 USD
P/E Ratio: 65.78
Exchange: PNK
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 505.7 million